Study questions Paxlovid’s COVID-19 ‘usefulness’ Researchers say the antiviral does little to reduce symptom duration for some vaccinated patients, but still recommended its use for the vulnerable.
Opioid prescriptions are down – but is dependence? While PBS listing revisions have potentially reduced opioid prescriptions, experts say more active treatment is required to reduce harm.
Drug expanded on PBS for CKD treatment GPs can now prescribe empagliflozin for eligible patients with chronic kidney disease, but should be aware of specific eligibility criteria.
Nearly 100 medicines added to 60-day dispensing list Treatments for diabetes, epilepsy, breast cancer, and menopause are among those now eligible for a longer prescription.
What is Ryeqo? While the medicine has already been available in Australia since 2022, it was recently approved for the treatment of endometriosis.
RACGP hails 60-day dispensing meeting Representatives from both sides of the contentious reform met last week to hash out differences and ensure patients are put first.
Medicine reforms save patients $250 million: Health Minister The past 12 months have brought a raft of changes to 60-day dispensing, the PBS, and bulk billing, but the sector is still crying out for funding.
Private opioid dependence scripts extended The Government will allow GPs to continue issuing private prescriptions until June next year, but the RACGP is calling for a permanent solution.
Respiratory-related antimicrobial prescribing ‘too high’: AURA 2023 Hundreds of Australians die each year due to drug-resistant infections exacerbated by antimicrobial overuse, according to the ACSQHC.
PBS authority process needs ‘serious revamp’: RACGP The ‘administrative and bureaucratic burden’ diverts GPs from patient care and contributes to burnout, the college has said.